Is Regeneron Pharmaceuticals (REGN) A Worthy Investment?
Oakmark Funds, an investment management firm, published its “Oakmark Select Fund” second quarter 2021 investor letter – a copy of which can be seen here. A return of 7...
Posts Tagged ‘NASDAQ:REGN’
Bronte Capital on Regeneron (REGN): “A Winner in Mouse Genetics”
Bronte Capital, an investment management firm, published its “Amalthea Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
10 Stocks that Beat Earnings Estimates
In this article we will take a look at the 10 stocks that beat the earnings estimates.
15 Most Valuable Biotech Companies in the World
In this article we will take a look at the 15 most valuable biotech companies in the world.
Is Regeneron Pharmaceuticals Inc (REGN) A Good Stock To Buy?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
5 Best Pharmaceutical Stocks to Buy According to Cathie Wood
In this article we discuss the 5 best pharmaceutical stocks to buy according to Cathie Wood.
Polen Focus Growth Fund Disposed its Regeneron Pharmaceuticals (REGN) Position, Here’s Why
Polen Capital, an investment management firm, published its “Polen Focus Growth” first quarter 2021 investor letter – a copy of which can be downloaded here.
10 Best Pharma Stocks to Buy Now
In this article we will take a look at the 10 best pharma stocks to buy now.
Is REGN Stock A Buy or Sell?
In this article we will analyze whether Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is a good investment right now by following the lead of some of the best investors in the world...
Is REGN A Good Stock To Buy Now?
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period.
Why Regeneron Pharmaceuticals (REGN) Stock is a Compelling Investment Case
Polen Capital Management recently released its Q3 2020 Investor Letter, a copy of which you can download here.
Were Hedge Funds Right About Embracing Regeneron Pharmaceuticals Inc (REGN)?
In this article we will check out the progression of hedge fund sentiment towards Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and determine whether it is a good investment right...
Hedge Funds Never Been More Bullish On Regeneron Pharmaceuticals Inc (REGN)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Were Hedge Funds Right About Piling Into Regeneron Pharmaceuticals Inc (REGN)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Trumpdesivir: Operation Warp Speed, “Engage.”
The COVID-19 vaccine race officially goes into high gear with the announcement of USA’s plan to test the 6-odd top vaccine candidates across upwards of 150,000 volunteers (...
Hedge Funds Aren’t Done Buying Regeneron Pharmaceuticals Inc (REGN)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Should You Be Tempted To ‘Sell’ Regeneron Pharmaceuticals (REGN) Stock
Distillate Capital recently released its Q1 2020 Investor Letter, a copy of which you can download below. The Distillate Capital’s U.S. Fundamental Stability & Value (U.S.
Stocks Amid COVID-19 Outbreak: Winners So Far in the Health Industry
At its worst on March 23rd, Dow Jones and the S&P declined by around 37% and 34%.
Polen Capital is Bullish on Regeneron Pharmaceuticals (REGN) and MSCI (MSCI)
Polen Capital Management, LLC, an independently-owned global investment manager, recently published its first-quarter focus growth commentary – a copy of which can be downloaded...
Hedge Fund and Insider Trading News: Anthony Scaramucci, Pierre Andurand, Howard Marks, East Lodge Capital, Regeneron Pharmaceuticals Inc (REGN), Siebert Financial Corp. (SIEB), and More
Hedge fund manager Ali Lumsden gained 73% the last time the mortgage-bond market went into meltdown. This time around, the veteran investor is on the wrong side of the crisis.
Hedge Fund and Insider Trading News: John Griffin, Jim Simons, Seth Klarman, Daniel Kamensky, Engaged Capital, JPMorgan Chase & Co. (JPM), Columbia Sportswear Company (COLM), and More
For Jim Simons, history is repeating itself, at least when it comes to meltdowns in the quant fund world.
Hedge Funds Have Never Been More Bullish On Regeneron Pharmaceuticals Inc (REGN)
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
2019 Review: Most Favored Hedge Fund Stocks vs. Regeneron Pharmaceuticals Inc (REGN)
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Did Hedge Funds Drop The Ball On Regeneron Pharmaceuticals Inc (REGN) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Have Never Been This Bullish On Regeneron Pharmaceuticals Inc (REGN)
Hedge funds run by legendary names like George Soros and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to...
Here’s What Hedge Funds Think About Regeneron Pharmaceuticals Inc (REGN)
Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in...
Is Regeneron Pharmaceuticals Inc (REGN) A Good Stock To Buy?
The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter, which unveil their equity positions...
Hedge Funds Are Crazy About Regeneron Pharmaceuticals Inc (REGN)
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good.
Regeneron Pharmaceuticals Inc (REGN)’s Dupixent Has Multi-Billion-Dollar Potential: Polen Capital
Florida-based investment manager Polen Capital is bullish on Regeneron Pharmaceuticals Inc (NASDAQ:REGN), a New York-based biotech company with six FDA-approved medicines and ...
Regeneron Pharmaceuticals Inc (REGN) and Sanofi SA (ADR) (SNY) Obtain Suspension of Injunction for Cholesterol Drug Sales
Correction: A previous version of this article erroneously presented older events about the case between Sanofi/Regeneron and Amgen.
11 Highest Paid CEOs In The World
Have you ever wondered which are the highest paid CEOs in the world? Companies in the corporate world are ready to push to the limits to compensate their CEOs, despite of the ...
Here’s Our Take On Horizon Pharma PLC (HZNP)’s Fall Out And Regeneron Pharmaceuticals Inc (REGN)’s EMA Hit
Thursday was a big day for two companies, in two very different ways, in the biotech space.
EMA Reviews Regeneron Pharmaceuticals Inc (REGN), Sanofi SA (ADR) (SNY) Dupixent MAA
The European Medicines Agency (EMA) has recently accepted to review the Marketing Authorization Application (MAA) of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (...
Hedge Funds Are Dumping Regeneron Pharmaceuticals Inc (REGN)
Out of thousands of stocks that are currently traded on the market, it is difficult to determine those that can really generate strong returns.
Regeneron Pharmaceuticals Inc (REGN) Faces Trouble With Eylea Amid Strong Sales
Eylea has been one of the main drivers of growth for Regeneron over the past couple of years.
Why Investors Are Watching Dean Foods, Regeneron Pharmaceuticals, Halliburton, and More
It's another quiet day on the Street as the main indexes are moderately in the green while the VIX is down 3% to trade below 15.
10 Most Successful Innovative Companies in The World in 2016
Bringing something new to the table is something that seems to be difficult these days, considering that many things have already been done, have already been invented, and have...
Here’s Why Amazon, Alphabet, Ocular Therapeutix, and Two Other Stocks Are Trending on Thursday
In this article, we will analyze the latest events surrounding Amazon.com, Inc.
Why RBS, Cheniere Energy, Regeneron Pharmaceuticals & Two Other Stocks Are in Spotlight Today
The major indexes opened higher on the last trading day of the quarter as some investors remain on the sidelines due to the Deutsche Bank uncertainty.
Healthcare Investor Sam Isaly Was Wrong About These 2 Stocks; Makes a Lot of Money on Freshly-Acquired Insurer
OrbiMed Advisors LLC is the world’s largest healthcare-focused investment firm, managing roughly $15 billion in net assets under management.
Hedge Funds Are Betting On Regeneron Pharmaceuticals Inc (REGN)
The market has been volatile as the Federal Reserve winds down its easy money policies.
Sivik Global Healthcare’s Top Biotech Stock Picks For Q4
Sivik Global Healthcare is a Greenwich, Connecticut-based healthcare-focused hedge fund founded by Krishen Sud in 2006.
Highlights From Viking Global’s Investor Letter: Alibaba Group Holding Ltd (BABA), Regeneron Pharmaceuticals Inc (REGN)
We have seen a copy of Viking Global's third quarter investor letter.
Regeneron Pharmaceuticals Inc (REGN) Calls Game, Set and Match On Its Competitor: Jim Cramer
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has, once again, shown today why biopharmaceuticals companies are so popular with investors, especially those with a speculative...
Samuel Isaly Says He Is Fond of Regeneron Pharmaceuticals Inc (REGN) & InterMune Inc (ITMN)
Samuel Isaly's Orbimed Advisors is one of the largest hedge funds focused almost entirely on the healthcare sector. In a recent intervention on CNBC, Mr.
Regeneron Pharmaceuticals Inc (REGN): Should You Follow in Sanofi SA (ADR) (SNY)’s Footsteps and Invest in This Booming Biotech?
More than anything, biotech companies need investors who are true believers in their products.
Sanofi SA (ADR) (SNY), Regeneron Pharmaceuticals Inc (REGN): Getting Closer
French drugmaker Sanofi SA (ADR) (NYSE:SNY) counted that much money in its coffers as of the end of June, including cash, cash equivalents, and short-term investments.
Regeneron Pharmaceuticals Inc (REGN), Viropharma Inc (VPHM): Sanofi SA (ADR) (SNY)’s Interest Sparks Biotech Stocks in a Huge Week for Investors
Looking for the best-performing sector in this year's big market rally? It may just be the biotech sector, which has erupted with astronomical gains in 2013.
GameStop Corp. (GME), Safeway Inc. (SWY), Regeneron Pharmaceuticals Inc (REGN): Friday’s Three Best Stocks
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Pfizer Inc. (PFE), Regeneron Pharmaceuticals Inc (REGN), Amgen, Inc. (AMGN): Invest in the Next Biotech Frontier
The last several months have been remarkably exciting in the biotech space.
